← Leaderboards
Victor F. Tapson
Duke University
$1,539,257
Attributed
$3,417,711
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$3,417,711 · 2
By mechanism
R44$2,817,681 · 1
U01$600,030 · 1
Top collaborators
- Sun Yong Jeong2 shared
- Guy L Reed2 shared
Most similar at Duke University
Same institution · by research overlap
- Christopher D Kontos$36,990,646
- Douglas Brock Cines$21,888,352
- Gowthami M Arepally$11,531,413
- Alisa S Wolberg$13,659,847
- Sreekanth Vemulapalli$3,194,344
Others in their field
Top investigators on “Venous Thrombosis”
- Paul M. Ridker · Brigham And Women'S Hospital$57,875,056
- Joel S. Bennett · University Of Pennsylvania$35,473,908
- John H Griffin · Scripps Research Institute$18,311,718
- Suresh Vedantham · Washington University$15,527,146
- Nicholas L Smith · University Of Washington$14,759,772
- Howard N Hodis · University Of Southern California$13,895,561
Research focus
Venous ThrombosisComputed Axial TomographyDiagnosis Design /EvaluationUltrasonographyClinical ResearchCooperative StudyNoninvasive DiagnosisLung Imaging /Visualization /ScanningPulmonary Circulation ObstructionAngiographyBioimaging /Biomedical ImagingThromboembolismHuman SubjectClinical TrialsBrain HemorrhageBrainAnticoagulationBlood Pressure ReductionCoagulation ProcessBlood FlowAffectBlood CoagulationClinical DataChronic Thromboembolic Pulmonary Hypertension
Grant awards (6)
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial$1,408,690
R44 · FY2022 · HL
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial$1,408,991
R44 · FY2021 · HL
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II$16,419
U01 · FY2003 · HL
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II$52,881
U01 · FY2002 · HL
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II$340,160
U01 · FY2001 · HL
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II$190,570
U01 · FY2000 · HL